Literature DB >> 10971419

Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review.

M S Rodgers1, J L McCall.   

Abstract

BACKGROUND: Liver resection for colorectal metastases is the only known treatment associated with long-term survival; extrahepatic disease is usually considered a contraindication to such treatment. However, some surgeons do not regard spread to the hepatic lymph nodes as a contraindication provided that these nodes can be excised adequately. A systematic review of the literature was undertaken to address this issue.
METHODS: An electronic search using Medline, Cancerlit and Embase databases was performed for studies reporting liver resection for colorectal metastases from 1964 to 1999. Data were extracted from papers reporting outcome for patients with positive hepatic nodes and analysed according to predetermined criteria.
RESULTS: Fifteen studies were identified that gave survival data on 145 node-positive patients. Five patients were reported to have survived 5 years after liver resection; one was disease free, two had recurrent disease and the disease status was not described in the remaining two. Five studies containing 83 patients specified a formal lymph node dissection as part of the surgical procedure and four of the five node-positive 5-year survivors were from these studies.
CONCLUSION: There are few 5-year survivors after liver resection, with or without lymph node dissection, for colorectal hepatic metastases involving the hepatic lymph nodes.

Entities:  

Mesh:

Year:  2000        PMID: 10971419     DOI: 10.1046/j.1365-2168.2000.01580.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  33 in total

Review 1.  Lymphatics and colorectal liver metastases: the case for sentinel node mapping.

Authors:  Christopher Christophi; Linh Nguyen; Vijayaragavan Muralidharan; Mehrdad Nikfarjam; Jonathan Banting
Journal:  HPB (Oxford)       Date:  2013-07-19       Impact factor: 3.647

Review 2.  Surgical resection versus non-surgical treatment for hepatic node positive patients with colorectal liver metastases.

Authors:  Kurinchi Selvan Gurusamy; Rajarajan Ramamoorthy; Charles Imber; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

3.  Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.

Authors:  Nozomu Machida; Kouji Yoshizaki; Narikazu Boku; Kentaro Yamazaki; Yusuke Onozawa; Akira Fukutomi; Hirofumi Yasui; Keisei Taku
Journal:  Int J Clin Oncol       Date:  2012-02-25       Impact factor: 3.402

4.  Resection of non-hepatic colorectal cancer metastasis.

Authors:  Fabian M Johnston; Peter J Kneuertz; Timothy M Pawlik
Journal:  J Gastrointest Oncol       Date:  2012-03

5.  Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis.

Authors:  Yoshinobu Mitsuyama; Hiroaki Shiba; Koichiro Haruki; Yuki Fujiwara; Kenei Furukawa; Tomonori Iida; Takenori Hayashi; Masaichi Ogawa; Yuichi Ishida; Takeyuki Misawa; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Oncol Lett       Date:  2012-01-18       Impact factor: 2.967

6.  Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.

Authors:  Moritz Koch; Peter Kienle; Ulf Hinz; Dalibor Antolovic; Jan Schmidt; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

7.  Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.

Authors:  Christopher Christophi; Mehrdad Nikfarjam; Caterina Malcontenti-Wilson; Vijayaragavan Muralidharan
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

Review 8.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases.

Authors:  Kenei Furukawa; Hiroaki Shiba; Koichiro Haruki; Yuki Fujiwara; Tomonori Iida; Yoshinobu Mitsuyama; Masaichi Ogawa; Yuichi Ishida; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  Oncol Lett       Date:  2012-05-17       Impact factor: 2.967

10.  Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer.

Authors:  Axel Kleespies; Kathrin E Füessl; Hendrik Seeliger; Martin E Eichhorn; Mario H Müller; Markus Rentsch; Wolfgang E Thasler; Martin K Angele; Martin E Kreis; Karl-Walter Jauch
Journal:  Int J Colorectal Dis       Date:  2009-06-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.